...
首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Quantification of mRNAs encoding proteins of the glycosphingolipid catabolism in mouse models of GM2 gangliosidoses and sphingolipid activator protein precursor (prosaposin) deficiency
【24h】

Quantification of mRNAs encoding proteins of the glycosphingolipid catabolism in mouse models of GM2 gangliosidoses and sphingolipid activator protein precursor (prosaposin) deficiency

机译:在GM2神经节苷脂酶和鞘脂激活蛋白前体(prosaposin)缺乏症的小鼠模型中编码糖鞘脂分解代谢蛋白的mRNA的定量

获取原文
获取原文并翻译 | 示例
           

摘要

We have investigated the mRNA amounts of six lysosomal proteins (β-hexosaminidase α- and β-subunit, sphingolipid activator protein precursor, GM2 activator protein, lysosomal sialidase, β-glucocerebrosidase) involved in the degradation of glycosphingolipids. We analyzed extracts from brain tissues of mouse models for lysosomal storage diseases, i.e., the GM2 gangliosidoses and the deficiency of the sphingolipid activator protein precursor (prosaposin). The mRNA levels were quantified by real-time reverse transcription-polymerase chain reaction. Although storage of the respective lysosomal proteins has been reported in human and mice, no increase of their mRNA amounts could be detected here. Our results indicate that there is no transcriptional upregulation of lysosomal proteins in the examined neuronal storage disorders.
机译:我们研究了参与糖鞘脂降解的六种溶酶体蛋白(β-己糖胺酶α-和β-亚基,鞘脂激活蛋白前体,GM2激活蛋白,溶酶唾液酸酶,β-葡萄糖脑苷脂酶)的mRNA量。我们分析了小鼠模型脑组织中的溶酶体贮积病,即GM2神经节苷脂和鞘脂激活蛋白前体(prosaposin)缺乏症的提取物。 mRNA水平通过实时逆转录-聚合酶链反应定量。尽管已经报道了在人和小鼠中各自溶酶体蛋白的储存,但是在这里不能检测到它们的mRNA量的增加。我们的结果表明在所检查的神经元存储障碍中没有溶酶体蛋白的转录上调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号